On Monday 26th of October Arcturus Therapeutics Holdin trades -8.29 percent lower
Arcturus Therapeutics Holdings shares hit a 52‑week low at $5.5, trading down 30% YTD – find the latest price, market cap & RNA therapy focus.
- ARCTURUS THERAPEUTICS HOLDIN
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read